Julie Krop - Aug 11, 2025 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role: Chief Marketing Officer
Signature: /s/ Joshua L. Colburn, attorney-in-fact
Stock symbol: DMAC
Transactions as of: Aug 11, 2025
Transactions value $: $0
Form type: 4
Date filed: 11/3/2025, 04:32 PM
Previous filing: Jun 12, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Krop Julie	Chief Marketing Officer	301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS	/s/ Joshua L. Colburn, attorney-in-fact	2025-11-03	0001643127

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DMAC	Stock Option (right to buy)	Award	$0	+450K		$0.00	450K	Aug 11, 2025	Common Stock	450K	$4.58	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.

Content

112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.